RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery

Summary

This pilot phase II trial is studying how well RO4929097 works in treating patients with stage III, or stage IV melanoma that can be removed by surgery. RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

Timeline

Start

2010-09

Primary completion

2011-11

Completion

—

Outcome

Outcome not reported

Stopped: “Study drug not available.”

Drugs

Indications